Bicycle Therapeutics Liability on Credit Line (Quarterly) Insights

Bicycle Therapeutics Plc (BCYC)

5.62 +0.18 (+3.31%) USD | NASDAQ | Feb 24, 10:38

View Liability on Credit Line (Quarterly) for BCYC.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Liability on Credit Line (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Liability on Credit Line (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Liability on Credit Line (Quarterly) Benchmarks

Start Trial

Biodexa Pharmaceuticals Plc	--
NuCana Plc	--
Mereo BioPharma Group Plc	--
Autolus Therapeutics Plc	--
DBV Technologies SA	--